Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz DDI with Methadone and Tizanidine in Healthy Volunteers
NCT05789173Phase 1Recruiting
- Sponsor
- Indiana University
- Start
- Oct 2023
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of efavirenz, methadone and tizanidine (2 arms), sponsored by Indiana University. Primary endpoints: Area Under the Curve (AUC0-∞) of Methadone and Area Under the Curve (AUC0-∞) of Tizanidine. Started Oct 2023; status: recruiting.
02
Drugs
efavirenzmethadonetizanidine
Beyond the preview
Go deeper on NCT05789173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05789173.